BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sato K, Yamazaki Y, Kobayashi T, Takakusagi S, Horiguchi N, Kakizaki S, Andou M, Matsuda Y, Uraoka T, Ohnishi H, Okamoto H. Sofosbuvir/Ribavirin therapy for patients experiencing failure of ombitasvir/paritaprevir/ritonavir + ribavirin therapy: Two cases report and review of literature. World J Clin Cases 2019; 7(9): 1043-1052 [PMID: 31123677 DOI: 10.12998/wjcc.v7.i9.1043]
URL: https://www.wjgnet.com/1007-9327/full/v7/i9/1043.htm
Number Citing Articles
1
Y Kanayama, K Sato, S Saito, T Ueno, Y Shimada, T Kohga, M Shibasaki, A Naganuma, S Takakusagi, T Nagashima, H Nakajima, H Takagi, D Uehara, T Uraoka. Prognosis and incidence of immunological and oncological complications after direct-acting antiviral therapy for chronic hepatitis CActa Gastro Enterologica Belgica 2022; 85(4): 601 doi: 10.51821/85.4.9925